speb/financial-data huggingface dataset:
CBAV.MC cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 61000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3449000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 19122000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 38188000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Gross PPE: 123740000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Invested Capital: 116611000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -17206000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 3374000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 54781000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 6344000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 61125000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -857000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Minority Interest: 1131000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Income: 12871000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 12871000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 12871000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 12871000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 12871000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 18058000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 12871000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Interest Income: -338000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -857000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -857000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -338000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 358000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -12058000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Net PPE: 123740000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -5148000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 72079000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1912000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 24139000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Normalized Income: 12871000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 24270000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Operating Income: 18396000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Operating Revenue: 80216000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 16005737.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 17787000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4747000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 56077000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Other Payable: 13321000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Other Properties: 123740000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Payables: 35282000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Pretax Income: 18058000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -5148000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5743000.00
CBAV.MC cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -857000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Share Issued: 16307580.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 110267000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 72079000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Tax Provision: 5187000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
CBAV.MC cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -778000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Assets: 230339000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 116611000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Debt: 61125000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 111398000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Total Expenses: 61820000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 118941000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 167214000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 65872000.00
CBAV.MC income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 18396000.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 301843.00
CBAV.MC balance_sheet (quarterly, 2025-03-31) — Working Capital: 10056000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — +Operating Expense: 42275000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — +Total Revenue: 74520000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 10846000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 6178000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 4894000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -6442000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1631000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 8528000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 40158000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -25462000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2341000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Changes In Cash: -5284000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Common Stock: 1631000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 90543000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Current Assets: 51876000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Current Debt: 2257000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2257000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 60538000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Current Provisions: 218000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 5632000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 5631000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 5631000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 9450000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — EBIT: 15021000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — EBITDA: 20653000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -5000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -25192000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 11846000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Goodwill: 28308000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 38468000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Inventory: 3419000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Invested Capital: 99483000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 1620000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2435000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 6683000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6683000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 58000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 5195000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Minority Interest: 1004000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Net Debt: 412000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Income: 9450000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 9450000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 9940000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 9450000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 9450000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 14356000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 9940000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Interest Income: -570000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -570000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -3473000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Net PPE: 127501000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6442000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 52075000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 1917000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 785000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 20653000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Normalized Income: 9450000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 18288000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Operating Income: 14798000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Operating Revenue: 74520000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 16008021.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1362000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 8404000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 789000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 10160000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -22446000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Payable: 10091000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Receivables: 650000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 31630000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Payables: 28597000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Pretax Income: 14356000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -6442000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 5632000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 22321000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Share Issued: 16307580.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 90543000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 52075000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Tax Provision: 4416000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.31
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 109000.00
CBAV.MC cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -4411000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Assets: 222255000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 97226000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Debt: 8940000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 91547000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Total Expenses: 59722000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 130708000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 170379000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 70170000.00
CBAV.MC income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 14686000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 7660000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 299559.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 8602000.00
CBAV.MC balance_sheet (quarterly, 2025-06-30) — Working Capital: -8662000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — +Operating Expense: 74160000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — +Total Revenue: 65302000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 21647000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 8939000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5750000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 58175000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 43854000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 43854000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -224000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1389000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7652000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 96437000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Current Assets: 52793000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 54124000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 6263000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 6264000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 6264000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 5976000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — EBIT: 8366000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — EBITDA: 14630000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 81000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4231000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 8420000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 38831000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Gross PPE: 131202000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Invested Capital: 104872000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2287000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 3150000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 58175000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 8435000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 66610000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Minority Interest: 925000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Income: 5976000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 5976000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 5486000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 5976000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 5976000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 8181000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 5486000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Interest Income: -280000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -280000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 3038000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Net PPE: 131202000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -5750000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 57606000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 2035000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 14630000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Normalized Income: 5976000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 14170000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Operating Income: 8589000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Operating Revenue: 65302000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 16012097.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 19731000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 9915000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 126986000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Other Payable: 12746000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Other Properties: 131202000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Payables: 34393000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Pretax Income: 8181000.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CBAV.MC cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -5750000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 6263000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Share Issued: 16307580.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 96437000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 57606000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Tax Provision: 2696000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.33
CBAV.MC cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -520000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Assets: 228011000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 104872000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Debt: 66610000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 97362000.00
CBAV.MC income_statement (quarterly, 2025-09-30) — Total Expenses: 56713000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 130649000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 175218000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 76525000.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 295483.00
CBAV.MC balance_sheet (quarterly, 2025-09-30) — Working Capital: -1331000.00
CBAV.MC income_statement (annual, 2025-12-31) — +Operating Expense: 207168128.00
CBAV.MC income_statement (quarterly, 2025-12-31) — +Operating Expense: 28913128.00
CBAV.MC income_statement (annual, 2025-12-31) — +Total Revenue: 301782236.00
CBAV.MC income_statement (quarterly, 2025-12-31) — +Total Revenue: 81744236.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Accounts Payable: 21447057.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 21447057.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Accounts Receivable: 4635589.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 4635589.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -156948928.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -156948928.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4893814.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4893814.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -496018.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -496018.00
CBAV.MC income_statement (annual, 2025-12-31) — Basic Average Shares: 16013795.00
CBAV.MC income_statement (annual, 2025-12-31) — Basic EPS: 2.63
CBAV.MC cash_flow (annual, 2025-12-31) — Beginning Cash Position: 10141037.00
CBAV.MC cash_flow (annual, 2025-12-31) — Capital Expenditure: -30012251.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -12672251.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 61232357.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 61232357.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Capital Stock: 1630758.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1630758.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5590371.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5590371.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 50424126.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 50424126.00
CBAV.MC cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -26406731.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -194731.00
CBAV.MC cash_flow (annual, 2025-12-31) — Change In Inventory: -42260.00
CBAV.MC cash_flow (annual, 2025-12-31) — Change In Payable: 8050197.00
CBAV.MC cash_flow (annual, 2025-12-31) — Change In Receivables: 283059.00
CBAV.MC cash_flow (annual, 2025-12-31) — Change In Working Capital: 8290996.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 6207996.00
CBAV.MC cash_flow (annual, 2025-12-31) — Changes In Cash: -4631185.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Changes In Cash: -10614185.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Common Stock: 1630758.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Common Stock: 1630758.00
CBAV.MC cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -26406731.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 109986203.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 109986203.00
CBAV.MC cash_flow (annual, 2025-12-31) — Common Stock Issuance: 3159769.00
CBAV.MC cash_flow (annual, 2025-12-31) — Common Stock Payments: -2387383.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Construction In Progress: 2789041.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 2789041.00
CBAV.MC income_statement (annual, 2025-12-31) — Cost Of Revenue: 33975633.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Current Assets: 59337316.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Current Assets: 59337316.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 11104640.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 11104640.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Current Debt: 2035525.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Current Debt: 2035525.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 13140165.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 13140165.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Current Liabilities: 61466104.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 61466104.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Current Provisions: 546279.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Current Provisions: 546279.00
CBAV.MC cash_flow (annual, 2025-12-31) — Depreciation: 23896954.00
CBAV.MC cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 23896954.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 6258954.00
CBAV.MC income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 23896954.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 6258954.00
CBAV.MC income_statement (annual, 2025-12-31) — Depreciation Income Statement: 23896954.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 6258954.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 6643110.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 6643110.00
CBAV.MC income_statement (annual, 2025-12-31) — Diluted Average Shares: 16013795.00
CBAV.MC income_statement (annual, 2025-12-31) — Diluted EPS: 2.63
CBAV.MC income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 42062662.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 13765662.00
CBAV.MC income_statement (annual, 2025-12-31) — EBIT: 62391462.00
CBAV.MC income_statement (quarterly, 2025-12-31) — EBIT: 20608462.00
CBAV.MC income_statement (annual, 2025-12-31) — EBITDA: 86288416.00
CBAV.MC income_statement (quarterly, 2025-12-31) — EBITDA: 26867416.00
CBAV.MC cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 80519.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -56481.00
CBAV.MC cash_flow (annual, 2025-12-31) — End Cash Position: 5590371.00
CBAV.MC cash_flow (annual, 2025-12-31) — Financing Cash Flow: -36454262.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3582262.00
CBAV.MC cash_flow (annual, 2025-12-31) — Free Cash Flow: 46827363.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 7439363.00
CBAV.MC cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -372143.00
CBAV.MC income_statement (annual, 2025-12-31) — General And Administrative Expense: 23565810.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Goodwill: 29007779.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Goodwill: 29007779.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 40091980.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 40091980.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 5131607.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 5131607.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Gross PPE: 299803337.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Gross PPE: 299803337.00
CBAV.MC income_statement (annual, 2025-12-31) — Gross Profit: 267806603.00
CBAV.MC income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 98933.00
CBAV.MC income_statement (annual, 2025-12-31) — Interest Expense: 2281005.00
CBAV.MC income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2281005.00
CBAV.MC income_statement (annual, 2025-12-31) — Interest Income: 1520873.00
CBAV.MC income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1520873.00
CBAV.MC cash_flow (annual, 2025-12-31) — Interest Paid Cff: -686924.00
CBAV.MC cash_flow (annual, 2025-12-31) — Interest Received Cfi: 1520873.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Inventory: 3324867.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Inventory: 3324867.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Invested Capital: 119374345.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Invested Capital: 119374345.00
CBAV.MC cash_flow (annual, 2025-12-31) — Investing Cash Flow: -45016537.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -27143537.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 0.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 0.00
CBAV.MC cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 3159769.00
CBAV.MC cash_flow (annual, 2025-12-31) — Issuance Of Debt: 3000000.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 50127717.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 50127717.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Long Term Debt: 7352617.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 7352617.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 57480334.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 57480334.00
CBAV.MC cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 3000000.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CBAV.MC cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2274379.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -507379.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 97682.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 97682.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Long Term Provisions: 5762959.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 5762959.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 154145197.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 154145197.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Minority Interest: 968960.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Minority Interest: 968960.00
CBAV.MC income_statement (annual, 2025-12-31) — Minority Interests: -872384.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -918500.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 500.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 772386.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Net Debt: 3797771.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Net Debt: 3797771.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Income: 42062662.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Income: 13765662.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 42062662.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 13765662.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 42935046.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 14638046.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 42062662.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 13765662.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 42062662.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 13765662.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 60110457.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 19515457.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 42935046.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 14638046.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Interest Income: -760132.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Interest Income: 427868.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -15606659.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 725621.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -507379.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 725621.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -507379.00
CBAV.MC income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -760132.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 427868.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 448000.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 525000.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Net PPE: 142854409.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Net PPE: 142854409.00
CBAV.MC cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -30012251.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -12672251.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 69894223.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 69894223.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 3156177.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 3156177.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1611068.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1611068.00
CBAV.MC income_statement (annual, 2025-12-31) — Normalized EBITDA: 86015206.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 26867416.00
CBAV.MC income_statement (annual, 2025-12-31) — Normalized Income: 41867516.52
CBAV.MC income_statement (quarterly, 2025-12-31) — Normalized Income: 13765662.00
CBAV.MC cash_flow (annual, 2025-12-31) — Operating Cash Flow: 76839614.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 20111614.00
CBAV.MC income_statement (annual, 2025-12-31) — Operating Income: 60638475.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Operating Income: 18855475.00
CBAV.MC income_statement (annual, 2025-12-31) — Operating Revenue: 301782236.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Operating Revenue: 81744236.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 16018514.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 16018514.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Current Assets: 857529.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 857529.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 8020000.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 8020000.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Equity Interest: 1070643.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1070643.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 11084201.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 11084201.00
CBAV.MC cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1227759.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Non Current Assets: -374491.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: -374491.00
CBAV.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 25918339.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -134698661.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Payable: 9500000.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Payable: 9500000.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Properties: 8235152.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Properties: 8235152.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Receivables: 95205.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 95205.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 44833755.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 44833755.00
CBAV.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Payables: 29907209.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Payables: 29907209.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1392170.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1392170.00
CBAV.MC income_statement (annual, 2025-12-31) — Pretax Income: 60110457.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Pretax Income: 19515457.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Properties: 134633947.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Properties: 134633947.00
CBAV.MC cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 736006.00
CBAV.MC cash_flow (annual, 2025-12-31) — Purchase Of Business: -918500.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 500.00
CBAV.MC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -35948003.00
CBAV.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -30012251.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -12672251.00
CBAV.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 33975633.00
CBAV.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 23896954.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6258954.00
CBAV.MC income_statement (annual, 2025-12-31) — Rent And Landing Fees: 2685935.00
CBAV.MC income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 2685935.00
CBAV.MC cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2274379.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -507379.00
CBAV.MC cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2387383.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: 42062662.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 42062662.00
CBAV.MC cash_flow (annual, 2025-12-31) — Sale Of Business: 2000.00
CBAV.MC cash_flow (annual, 2025-12-31) — Sale Of Investment: 20341344.00
CBAV.MC income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 15091335.00
CBAV.MC income_statement (annual, 2025-12-31) — Selling General And Administration: 38657145.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Share Issued: 16307580.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Share Issued: 16307580.00
CBAV.MC income_statement (annual, 2025-12-31) — Special Income Charges: -98933.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 109986203.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 109986203.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 69894223.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 69894223.00
CBAV.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 78064.52
CBAV.MC income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBAV.MC income_statement (annual, 2025-12-31) — Tax Provision: 17175411.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Tax Provision: 4876411.00
CBAV.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.29
CBAV.MC income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.25
CBAV.MC balance_sheet (annual, 2025-12-31) — Taxes Receivable: 0.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 0.00
CBAV.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -17326467.00
CBAV.MC cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -11247467.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Assets: 247507618.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Assets: 247507618.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 117338820.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 117338820.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Debt: 70620499.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Debt: 70620499.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 110955163.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 110955163.00
CBAV.MC income_statement (annual, 2025-12-31) — Total Expenses: 241143761.00
CBAV.MC income_statement (quarterly, 2025-12-31) — Total Expenses: 62888761.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 136552455.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 136552455.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 188170302.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 188170302.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 75086351.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 75086351.00
CBAV.MC income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 60539543.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 8460152.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 8460152.00
CBAV.MC income_statement (annual, 2025-12-31) — Total Unusual Items: 273210.00
CBAV.MC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 273210.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 289066.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 289066.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Treasury Stock: 8422317.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 8422317.00
CBAV.MC balance_sheet (annual, 2025-12-31) — Working Capital: -2128788.00
CBAV.MC balance_sheet (quarterly, 2025-12-31) — Working Capital: -2128788.00
CBAV.MC income_statement (quarterly, 2026-03-31) — +Operating Expense: 67243000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — +Total Revenue: 86974000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 25613000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 9470000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 6635000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 16025113.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Basic EPS: 0.92
CBAV.MC cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5804000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 60727000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 64835000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 64835000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1724000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Changes In Cash: 15381000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 124246000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Current Assets: 74305000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 59735000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 6635000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 6635000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 6635000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 16025113.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.92
CBAV.MC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 14700000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — EBIT: 19731000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — EBITDA: 26366000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -25000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -3483000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 17723000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 40734000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Gross PPE: 142889000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 131666000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -4663000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 2727000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 60727000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7420000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 68147000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -508000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1273000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Income: 14700000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 14700000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 14700000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 14700000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 14700000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 20106000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 14700000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Interest Income: 375000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -508000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -508000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 375000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -81000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 1141000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Net PPE: 142889000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -5804000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 83512000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 3213000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 26366000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Normalized Income: 14700000.00
CBAV.MC cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 23527000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Operating Income: 19731000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Operating Revenue: 86974000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 16025113.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 18330000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 10467000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 60608000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Other Payable: 15792000.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Other Properties: 142889000.00
CBAV.MC income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CBAV.MC balance_sheet (quarterly, 2026-03-31) — Payables: 41405000.00